$20.04
-0.02-0.1%
Last update: Sep 17, 2:03 PM
Denali Therapeutics Inc
DNLINASDAQ
Denali Therapeutics Earnings & Forecasts
Denali Therapeutics (DNLI) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Denali Therapeutics Guidance
Recent Earnings Results
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.57 | $-0.71 | $-0.75 | $-0.76 |
| Actual | $-0.68 | $-0.69 | $-0.73 | $-0.74 |
| Surprise | -19.3% | +2.82% | +2.67% | +2.63% |
| Revenue | ||||
| Estimate | $2.0M | $3.8M | $9.0M | $6.2M |
| Actual | $3.6M | $0 | $0 | $0 |
| Surprise | +77.2% | -100.0% | -100.0% | -100.0% |
Analyst Estimates — Forward PeriodsSource: Wall Street consensus
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.43 | $-0.62 | $-0.54 | $-0.56 |
| Revenue | ||||
| Consensus | $20.8M | $24.8M | — | — |
